Alnylam Pharmaceuticals (ALNY) News Today → The Department of Defense Has a New Drone Contractor (From The Tomorrow Investor) (Ad) Free alny Stock Alerts $154.33 +3.11 (+2.06%) (As of 05/7/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHC Wainwright Increases Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target to $400.00marketbeat.com - May 7 at 8:32 AMPureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointmentsfinance.yahoo.com - May 7 at 7:44 AMLos Angeles Capital Management LLC Invests $3.26 Million in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - May 6 at 7:45 AMAlnylam Pharmaceuticals' (ALNY) Buy Rating Reiterated at Chardan Capitalamericanbankingnews.com - May 6 at 3:44 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Chardan Capitalamericanbankingnews.com - May 5 at 4:12 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Stock Rating Reaffirmed by Needham & Company LLCamericanbankingnews.com - May 4 at 2:14 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Issues Earnings Resultsmarketbeat.com - May 3 at 10:39 PMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Q1 2024 Earnings Call Transcriptfinance.yahoo.com - May 3 at 8:28 PMStrong Financial Growth and Promising Clinical Trials Bolster Buy Rating for Alnylam Pharmaceuticalsmarkets.businessinsider.com - May 3 at 10:14 AMAlnylam Pharmaceuticals First Quarter 2024 Earnings: Beats Expectationsfinance.yahoo.com - May 3 at 10:14 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Given Buy Rating at Chardan Capitalmarketbeat.com - May 3 at 9:31 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Position Trimmed by Van ECK Associates Corpmarketbeat.com - May 3 at 6:20 AMAlnylam Pharmaceuticals Inc (ALNY) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth ...finance.yahoo.com - May 3 at 5:12 AMNeedham & Company LLC Reaffirms Buy Rating for Alnylam Pharmaceuticals (NASDAQ:ALNY)marketbeat.com - May 2 at 3:39 PMAlnylam: Q1 Earnings Snapshotsfgate.com - May 2 at 1:39 PMALNY Stock Earnings: Alnylam Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024investorplace.com - May 2 at 1:03 PMAlnylam Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - May 2 at 11:36 AMAlnylam Pharmaceuticals Non-GAAP EPS of -$0.16 beats by $0.32, revenue of $494.3M beats by $67.44Mmsn.com - May 2 at 8:38 AMAlnylam Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Period Activitybusinesswire.com - May 2 at 8:00 AMHere's what Wall Street expects from Alnylam Pharmaceuticals's earningsmarkets.businessinsider.com - May 1 at 3:31 PMAlnylam, Medison Expand Partnership To Market RNAi Therapeutics In Addnl. LATAM And APAC Marketsmarkets.businessinsider.com - April 30 at 9:49 AMMedison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australiaprnewswire.com - April 30 at 7:00 AMShort Interest in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Declines By 10.7%americanbankingnews.com - April 30 at 6:22 AMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Receives Average Rating of "Moderate Buy" from Brokeragesamericanbankingnews.com - April 30 at 4:30 AM5 Most Promising Stocks to Buy Before They Take Offinsidermonkey.com - April 29 at 2:26 PMShort Interest in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Decreases By 10.7%marketbeat.com - April 29 at 7:13 AMStockNews.com Upgrades Alnylam Pharmaceuticals (NASDAQ:ALNY) to Buyamericanbankingnews.com - April 29 at 2:26 AMCompare with Ironwood Pharmaceuticals Inc (IRWD)msn.com - April 28 at 9:24 AMSector Gamma AS Sells 20,876 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 27 at 4:38 PMAlnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 52-Week Low at $142.14americanbankingnews.com - April 27 at 5:32 AMOligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarkets™finance.yahoo.com - April 26 at 3:50 PMOligonucleotide Synthesis Market Worth $19.7 billion | MarketsandMarketsfinanznachrichten.de - April 26 at 10:49 AMEQS-News: BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest ratesmarkets.businessinsider.com - April 26 at 1:49 AMAlnylam Pharmaceuticals (NASDAQ:ALNY) Reaches New 52-Week Low at $142.14marketbeat.com - April 25 at 3:45 PMAlnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Stock Position Lowered by Handelsbanken Fonder ABmarketbeat.com - April 24 at 6:48 AMDuality Advisers LP Buys 7,682 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 22 at 11:53 AMZurcher Kantonalbank Zurich Cantonalbank Grows Stock Position in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 21 at 5:43 AMHow Is The Market Feeling About Alnylam Pharmaceuticals?benzinga.com - April 19 at 4:47 PMAlnylam Pharmaceuticals (NASDAQ:ALNY) Sets New 1-Year Low at $143.50marketbeat.com - April 19 at 3:27 PMAlnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Resultsbusinesswire.com - April 18 at 8:00 AM3 Biotech Stocks Paving the Way for Bullish Investment Gainsstocknews.com - April 17 at 4:06 PMLevi & Korsinsky Reminds Alnylam Investors of the Ongoing Investigation into Potential Violations of Securities Laws - ALNYmarkets.businessinsider.com - April 17 at 10:25 AMMirae Asset Global Investments Co. Ltd. Sells 22,532 Shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 14 at 5:19 AMAlnylam Pharmaceuticals, Inc. Forecasted to Earn Q1 2024 Earnings of ($1.17) Per Share (NASDAQ:ALNY)marketbeat.com - April 12 at 6:09 AMRegeneron Pharmaceuticals's Options: A Look at What the Big Money is Thinkingbenzinga.com - April 11 at 1:00 PMFY2028 EPS Estimates for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Raised by Analystmarketbeat.com - April 11 at 8:16 AMBuy Rating Affirmed for Alnylam Pharma on Strong Zilebesiran Trial Results and Lucrative Roche Partnershipmarkets.businessinsider.com - April 9 at 6:29 PMBaillie Gifford & Co. Has $1.33 Billion Stock Holdings in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)marketbeat.com - April 9 at 11:57 AMWegovy Helps HFpEF Patients With Diabetes Mellitusmsn.com - April 8 at 5:27 PMStudy shows promise of zilebesiran injection in reducing systolic blood pressuremsn.com - April 8 at 5:27 PM Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. ALNY Media Mentions By Week ALNY Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALNY News Sentiment▼0.460.38▲Average Medical News Sentiment ALNY News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALNY Articles This Week▼258▲ALNY Articles Average Week Get Alnylam Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ALNY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Royalty Pharma News BioMarin Pharmaceutical News United Therapeutics News Ionis Pharmaceuticals News Genmab A/S News Teva Pharmaceutical Industries News BeiGene News Viatris News Karuna Therapeutics News Dr. Reddy's Laboratories News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALNY) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorElon Musk Secret Crypto Plot ExposedCrypto 101 MediaThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alnylam Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
